• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Oracle Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket

    6/12/24 5:33:47 AM ET
    $AAN
    $AYRO
    $BMR
    $CLDI
    Diversified Commercial Services
    Consumer Discretionary
    Telecommunications Equipment
    Consumer Discretionary
    Get the next $AAN alert in real time by email

    Shares of Oracle Corporation (NYSE:ORCL) rose sharply in today's pre-market trading after the company reported fourth-quarter financial results.

    Oracle posted weaker-than-expected earnings for its fiscal fourth quarter. The company also announced a partnership with Alphabet Inc’s (NASDAQ:GOOGL) (NASDAQ:GOOG) Google Cloud.

    Oracle shares jumped 9% to $135.00 in the pre-market trading session.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Golden Heaven Group Holdings Ltd (NASDAQ:GDHG) rose 70.3% to $0.3049 in today's pre-market trading.
    • WANG & LEE GROUP, Inc. (NASDAQ:WLGS) shares rose 43.1% to $0.8760 in pre-market trading after surging 16% on Tuesday.
    • Surf Air Mobility Inc. (NYSE:SRFM) gained 38% to $0.3860 in pre-market trading. Surf Air Mobility entered into an agreement to supply electric powertrains to Asta, a Brazilian Cessna Caravan operator.
    • Beamr Imaging Ltd. (NASDAQ:BMR) gained 28.2% to $5.64 in pre-market trading. Beamr said its cloud solution is now available in the Oracle Cloud Marketplace.
    • Castellum, Inc. (NYSE:CTM) shares gained 24.9% to $0.2410 in pre-market trading.
    • Rentokil Initial plc (NYSE:RTO) gained 11.5% to $30.01 in pre-market trading following a report suggesting Trian has amassed a stake in the company.
    • The Aaron’s Company, Inc. (NYSE:AAN) shares climbed 10.9% to $8.88 in pre-market trading.
    • Mereo BioPharma Group plc (NASDAQ:MREO) rose 10.8% to $3.90 in pre-market trading. Ultragenyx and Mereo reported 14-month results from Phase 2 portion of Phase 2/3 Orbit study.
    • Ayro, Inc. (NASDAQ:AYRO) shares rose 9.6% to $0.8991 in pre-market trading.

    Losers

    • ThermoGenesis Holdings, Inc. (NASDAQ:THMO) shares declined 49.8% to $0.2691 in pre-market trading after the Nasdaq denied the company’s request for continued listing and the stock will be suspended at the opening of business on June 17, 2024.
    • Clene Inc. (NASDAQ:CLNN) shares dipped 24.7% to $0.31 in pre-market trading after falling 4% on Tuesday.
    • Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) shares declined 24.4% to $1.61 in pre-market trading after announcing a proposed public offering.
    • KWESST Micro Systems Inc. (NASDAQ:KWE) shares fell 21.9% to $0.7965 in pre-market trading after jumping around 17% on Tuesday. KWESST Micro Systems was recently awarded a sub-contract worth up to C$48 million by Thales Canada for software development services.
    • ShiftPixy, Inc. (NASDAQ:PIXY) shares declined 14.3% to $1.32 in pre-market trading after gaining over 5% on Tuesday.
    • Oblong, Inc. (NASDAQ:OBLG) fell 14.2% to $0.1723 in pre-market trading after declining 5% on Tuesday. Obglong recently signed a non-binding letter of intent to acquire Dwellwell Analytics.
    • PetMed Express, Inc. (NASDAQ:PETS) shares fell 13.8% to $4.06 in pre-market trading following mixed fourth-quarter results. The company said results were negatively impacted by a challenging macro environment and industry dynamics.
    • mF International Limited (NASDAQ:MFI) shares fell 13% to $0.99 in pre-market trading after surging around 13% on Tuesday.
    • Calidi Biotherapeutics, Inc. (NYSE:CLDI) shares fell 12.2% to $0.2370 in pre-market trading after jumping around 32% on Tuesday. Calidi Biotherapeutics recently announced collaboration with SIGA Technologies to advance Calidi’s RTNova virotherapy for lung cancer and metastatic solid tumors.
    • Big Tree Cloud Holdings Limited (NASDAQ:DSY) shares fell 11.9% to $2.45 in pre-market trading after dipping 23% on Tuesday. Big Tree Cloud recently announced completion of its business combination with Plutonian Acquisition Corp.

    Now Read This: S&P 500, Nasdaq Hit Record Highs As Apple Shares Surge: Fear And Greed Index Shows Progress Amid Improving Market Sentiment

    Get the next $AAN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAN
    $AYRO
    $BMR
    $CLDI

    CompanyDatePrice TargetRatingAnalyst
    Oracle Corporation
    $ORCL
    2/25/2026$185.00Perform → Outperform
    Oppenheimer
    Rentokil Initial plc
    $RTO
    2/24/2026Buy → Hold
    Deutsche Bank
    Alphabet Inc.
    $GOOGL
    2/23/2026$387.00Equal Weight → Overweight
    Wells Fargo
    Oracle Corporation
    $ORCL
    2/9/2026Buy → Hold
    Melius
    Oracle Corporation
    $ORCL
    2/9/2026$180.00Neutral → Buy
    DA Davidson
    Alphabet Inc.
    $GOOG
    2/5/2026$400.00 → $420.00Buy
    Pivotal Research Group
    Oracle Corporation
    $ORCL
    2/4/2026$270.00 → $205.00Outperform
    BMO Capital Markets
    Alphabet Inc.
    $GOOGL
    1/26/2026$330.00 → $360.00Overweight
    KeyBanc Capital Markets
    More analyst ratings

    $AAN
    $AYRO
    $BMR
    $CLDI
    SEC Filings

    View All

    Alphabet Inc. filed SEC Form 8-K: Leadership Update

    8-K - Alphabet Inc. (0001652044) (Filer)

    3/6/26 5:21:44 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    SEC Form S-3MEF filed by Calidi Biotherapeutics Inc.

    S-3MEF - Calidi Biotherapeutics, Inc. (0001855485) (Filer)

    3/5/26 9:59:34 PM ET
    $CLDI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Castellum Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Castellum, Inc. (0001877939) (Filer)

    3/5/26 4:02:54 PM ET
    $CTM
    Professional Services
    Consumer Discretionary

    $AAN
    $AYRO
    $BMR
    $CLDI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Matlin David J bought $216,664 worth of shares (33,333 units at $6.50), increasing direct ownership by 7% to 477,824 units (SEC Form 4)

    4 - Clene Inc. (0001822791) (Issuer)

    1/13/26 2:48:54 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Holst Peter bought $9,500 worth of shares (5,000 units at $1.90), increasing direct ownership by 47% to 15,544 units (SEC Form 4)

    4 - Oblong, Inc. (0000746210) (Issuer)

    11/19/25 3:15:50 PM ET
    $OBLG
    Computer Software: Programming Data Processing
    Technology

    President and CEO Holst Peter bought $18,400 worth of shares (10,000 units at $1.84), increasing direct ownership by 1,838% to 10,544 units (SEC Form 4)

    4 - Oblong, Inc. (0000746210) (Issuer)

    11/17/25 1:12:26 PM ET
    $OBLG
    Computer Software: Programming Data Processing
    Technology

    $AAN
    $AYRO
    $BMR
    $CLDI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Pichai Sundar sold $9,859,694 worth of Class C Capital Stock (32,500 units at $303.38) and was granted 265,001 units of Class C Google Stock Units, decreasing direct ownership by 84% to 265,001 units (SEC Form 4)

    4 - Alphabet Inc. (0001652044) (Issuer)

    3/6/26 5:43:01 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    Director Arnold Frances sold $33,935 worth of Class C Capital Stock (112 units at $302.99), decreasing direct ownership by 0.60% to 18,418 units (SEC Form 4)

    4 - Alphabet Inc. (0001652044) (Issuer)

    3/4/26 5:31:50 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    VP, Chief Accounting Officer O'Toole Amie Thuener sold $284,590 worth of Class C Capital Stock (955 units at $298.00), decreasing direct ownership by 9% to 9,918 units (SEC Form 4)

    4 - Alphabet Inc. (0001652044) (Issuer)

    3/4/26 5:31:03 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    $AAN
    $AYRO
    $BMR
    $CLDI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Oracle upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Oracle from Perform to Outperform and set a new price target of $185.00

    2/25/26 7:38:35 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Rentokil Initial plc downgraded by Deutsche Bank

    Deutsche Bank downgraded Rentokil Initial plc from Buy to Hold

    2/24/26 7:44:25 AM ET
    $RTO
    Other Consumer Services
    Consumer Discretionary

    Alphabet A upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Alphabet A from Equal Weight to Overweight and set a new price target of $387.00

    2/23/26 8:28:41 AM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    $AAN
    $AYRO
    $BMR
    $CLDI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering

    SAN DIEGO, March 06, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE:CLDI) ("Calidi" or the "Company"), a biotechnology company pioneering the development of targeted genetic medicines, today announced the pricing of its underwritten public offering of 10,519,631 units, with each unit consisting of one share of common stock (or pre-funded warrant in lieu thereof), (ii) one 6 month warrant to purchase one share of common stock, (iii) one 12 month warrant to purchase one share of common stock and (iv) one five year warrant to purchase one share of common stock (collectively, the "Warrants") . Ladenburg Thalmann & Co. Inc. is acting as sole book-running manager for the offering.

    3/6/26 8:30:00 AM ET
    $CLDI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Calidi Biotherapeutics Announces Proposed Public Offering

    SAN DIEGO, March 05, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE:CLDI) ("Calidi" or the "Company"), a biotechnology company pioneering the development of targeted genetic medicines, today announced that it intends to offer and sell, subject to market and other conditions, units consisting of shares of its common stock and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock, in an underwritten public offering. Each share of common stock or pre-funded warrant will be sold with accompanying common warrants to purchase shares of common stock (or a pre-funded warrant in lieu thereof). The shares of common stock

    3/5/26 5:57:29 PM ET
    $CLDI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development

    Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the first new FDA-approved treatment for fibromyalgia in adults in more than 15 years The sublingual TONMYA tablet containing a basifying agent achieved the design objectives of rapid transmucosal absorption and bypassing first-pass liver metabolism TONMYA was designed to decrease production of the active metabolite norcyclobenzaprine, which is believed to improve the durability of analgesic response in fibromyalgia relative to the transient (~1 month) effects of oral, swallowed cyclobenzaprine BERKELEY HEIGHTS, N.J., March 05, 2026 (GLOBE NEWSWIRE

    3/5/26 4:15:00 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAN
    $AYRO
    $BMR
    $CLDI
    Leadership Updates

    Live Leadership Updates

    View All

    Calidi Biotherapeutics Provides Corporate Update and Key Value Drivers for 2026

    Company intends to file an IND in Q4 2026 for its first RedTail lead candidate, CLD-401, a systemically delivered and targeted genetic medicine engineered to deliver high concentrations of IL-15 superagonist to the tumor microenvironment in patients with metastatic disease.Calidi expects to present proof of concept data demonstrating the versatility of the RedTail platform and expanding its oncology platform with new payloads including the simultaneous delivery of tumor-localized BiTEs alongside T-cell amplifiers.Calidi expects to present proof of concept data demonstrating the applicability of the RedTail platform in non-oncology indications. SAN DIEGO, Jan. 28, 2026 (GLOBE NEWSWIRE) --

    1/28/26 8:00:00 AM ET
    $CLDI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Big Tree Cloud Holdings Limited Announces AI Business Expansion, Key Management Appointments and Changes

    SHENZHEN, China, Jan. 2, 2026 /PRNewswire/ -- Big Tree Cloud Holdings Limited (the "Company", or "Big Tree Cloud") (NASDAQ:DSY) today announced its expansion into new AI business lines and the appointment of key talents to support its long-term growth strategy. Due to business adjustments, the Company has decided to restructure the relevant teams. Mr. Yumao Huang has stepped down from the Board of Directors (the "Board"). Mr. Huang has served as a director of the Company since March 2024. His resignation is not a result of any disagreement with management of the Company or the Board, and there is no matter relating to his resignation that needs to be brought to the attention of the Company'

    1/2/26 8:30:00 AM ET
    $DSY
    Containers/Packaging
    Consumer Discretionary

    Tonix Pharmaceuticals Appoints Irina Ishak as General Counsel

    CHATHAM, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix" or the "Company"), a fully integrated commercial-stage biotechnology company today announced the appointment of Irina Ishak as General Counsel, effective December 8, 2025. Ms. Ishak will lead Tonix's legal, corporate governance, and compliance functions. "Irina is a highly accomplished corporate and commercial attorney whose experience spans public and private life sciences companies, as well as advising life sciences investors," said Seth Lederman, M.D., President and Chief Executive Officer of Tonix. "Her deep background in complex transactions, public company matters, and governa

    12/9/25 7:00:00 AM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAN
    $AYRO
    $BMR
    $CLDI
    Financials

    Live finance-specific insights

    View All

    Oracle Sets the Date for its Third Quarter Fiscal Year 2026 Earnings Announcement

    Earnings Results to be released on March 10, 2026, After the Close of the MarketAUSTIN, Texas, March 3, 2026 /PRNewswire/ -- Oracle Corporation today announced that its third quarter fiscal year 2026 results will be released on Tuesday, March 10th, after the close of the market. Oracle will host a conference call and live webcast at 4:00 p.m. Central Time to discuss the financial results.  The live webcast will be available on the Oracle Investor Relations website at www.oracle.com/investor. About OracleOracle offers integrated suites of applications plus secure, autonomous infr

    3/3/26 4:00:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Surf Air Mobility to Announce Fourth Quarter and Year-end 2025 Financial Results on March 12, 2026

    Surf Air Mobility Inc. (NYSE:SRFM) a leading air mobility platform, today announced that it will release its fourth quarter and year-end 2025 financial results after market close on Thursday, March 12, 2026, and will host a webcast at 5:00 pm ET the same day. Interested parties can register in advance to listen to the webcast here or can find a link on the ‘Events & Presentations' section of our investor relations website. Alternatively, listeners may dial into the call as follows: North America - Toll-Free (800) 715-9871 International (Toll) - (646) 307-1963 Conference ID: 4775356 About Surf Air Mobility Surf Air Mobility is a Los Angeles-based air mobility platform. With its AI-en

    2/26/26 4:05:00 PM ET
    $SRFM
    Transportation Services
    Consumer Discretionary

    Oracle Announces Fiscal Year 2026 Second Quarter Financial Results

    Q2 Remaining Performance Obligations $523 billion, up 438% in USDQ2 GAAP Earnings per Share up 91% to $2.10, Non-GAAP Earnings per Share up 54% to $2.26Q2 Total Revenue $16.1 billion, up 14% in USD and up 13% in constant currencyQ2 Cloud Revenue (IaaS plus SaaS) $8.0 billion, up 34% in USD and up 33% in constant currencyQ2 Cloud Infrastructure (IaaS) Revenue $4.1 billion, up 68% in USD and up 66% in constant currencyQ2 Cloud Application (SaaS) Revenue $3.9 billion, up 11% in both USD and constant currencyQ2 Fusion Cloud ERP (SaaS) Revenue $1.1 billion, up 18% in USD and up 17% in constant currencyQ2 NetSuite Cloud ERP (SaaS) Revenue $1.0 billion, up 13% in both USD and constant currencyAUSTI

    12/10/25 4:05:00 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $AAN
    $AYRO
    $BMR
    $CLDI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by KWESST Micro Systems Inc.

    SC 13G - KWESST Micro Systems Inc. (0001889823) (Subject)

    11/14/24 5:34:02 PM ET
    $KWE
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Tonix Pharmaceuticals Holding Corp.

    SC 13G/A - Tonix Pharmaceuticals Holding Corp. (0001430306) (Subject)

    11/14/24 4:42:22 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Tonix Pharmaceuticals Holding Corp.

    SC 13G/A - Tonix Pharmaceuticals Holding Corp. (0001430306) (Subject)

    11/14/24 4:40:17 PM ET
    $TNXP
    Biotechnology: Pharmaceutical Preparations
    Health Care